So let ME get this right...
1) You refuse to answer the questions from the post you commented on (still waiting).
2) Key updates? What exactly have those key updates been that have impacted the bottom line? What answers have you provided that can't be answered with a legal approved stock email or by Googling? Again, how many docs a day/week do you actually speak to? How many in person? Also, what exactly is your role in facilitating these relationships for research? Passing it on to someone else? How many sites are you convincing to take on research or is it the other way around? Give me a break.
3) Congrats on being ranked top of group that does not contribute much to the bottom line. BTW, I don't think that anyone said that MSLs were worthless. This is in response to thinking that you contribute even close to as much to the bottom line as sales people. You do not.
-I guarantee you I have more overnights than you, and that most MSLs have more overnights than you. This is a function of our territory being 4x a sales reps territory..... It shows how little you work with MSLs.
-You seem fixated on #'s of engagements vs ignoring quality of engagement. We engage at the frequency the companies leadership expects us too. Just like your metrics are designed and frequency of outreach dictated by company standards...
-I'll take my 2 hour dinner over your 60 second meetings any day of the week.... Especially if we are talking about ability to have impact and change HCP behavior.
-If we are speaking of interaction frequency... We all know how padded sale interaction #s are. I have reps that spend thousands in office lunches, log in interactions for the entire 50 office staff, and get 60 seconds with a low tier HCP. I'll take my multi-hour dinner with a KOL that treats thousands of patients over your 60 second "High, here is a donut, how are you. Ok, I appreciate you are busy, let me regurgitate a 60 second sound bite as you walk out the door" low tier HCP engagement.
-Field medical clearly has better access to TOP KOLs than sales reps by and large. Yes you introduce us to low tier and low volume writers. This is not the case for key KOLs and academic centers.
- Conference and off-label discussions not impactful?! Oh wait, during covid, what type of conversations were you able to have? Those silly conference updates you think aren't important, were communicated by MSLs, and placed in context by MSLs. Anyone saying the MSL hasn't contributed tremendously to bottom line during the pandemic is dumb as fuck. You really are clueless.
-You also show your ignorance in terms of the MSL role in facilitating research. This company has NUMEROUS clinical trials that would have achieved recruitment or number of sites had it not been for the MSL teams. That is not opinion. That is fact. I have seen the numbers. We play a vital role in fostering that. In fact, many initiatives of ours are based on HCPs not responding to the clinical operations teams...
To say we don't contribute significantly to bottom line is hilarious. A skilled MSL is worth their weight in gold in terms of getting HCPs to modify prescribing behavior. Again, if Victor didn't think MSLs were impacting bottom line in a very significant manner, we would be gone in seconds. HCP time is precious and pharma companies recognized the importance of having PhD/MD and Pharm D trained therapeutic expertise engaging our HCPS. If not, we would be the first to let go.
Again, you reps have a role in the company as do MSLs. We have different roles, but to claim MSLs are huge + in the bottom line is just stupid.